- Home
- STKE vs NTRB Comparison
STKE vs NTRB Comparison
Compare STKE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STKE | NTRB |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.4M | 57.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STKE | NTRB |
|---|---|---|
| Price | $2.20 | $4.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 320.0K | 61.2K |
| Earning Date | 01-06-2026 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,456,249.00 | $2,278,321.00 |
| Revenue This Year | $45.67 | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 37.18 | 12.69 |
| 52 Week Low | $1.50 | $3.90 |
| 52 Week High | $34.32 | $11.78 |
Technical Indicators
Market Signals| Indicator | STKE | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.33 |
| Support Level | N/A | $4.17 |
| Resistance Level | N/A | $4.49 |
| Average True Range (ATR) | 0.00 | 0.34 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 12.50 |
Price Performance
Historical ComparisonAbout STKE Sol Strategies Inc.
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.